Cargando…
Recent progress in vaccine development targeting pre-clinical human toxoplasmosis
Toxoplasma gondii is an intracellular parasitic organism affecting all warm-blooded vertebrates. Due to the unavailability of commercialized human T. gondii vaccine, many studies have been reported investigating the protective efficacy of pre-clinical T. gondii vaccines expressing diverse antigens....
Autores principales: | Chu, Ki-Back, Quan, Fu-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Parasitology and Tropical Medicine
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471472/ https://www.ncbi.nlm.nih.gov/pubmed/37648228 http://dx.doi.org/10.3347/PHD.22097 |
Ejemplares similares
-
Clinical Features and Treatment of Ocular Toxoplasmosis
por: Park, Young-Hoon, et al.
Publicado: (2013) -
Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development
por: Chu, Ki-Back, et al.
Publicado: (2021) -
Landscape and progress of global COVID-19 vaccine development
por: Huang, Hui-Yao, et al.
Publicado: (2021) -
Granulation techniques and technologies: recent progresses
por: Shanmugam, Srinivasan
Publicado: (2015) -
SOCE and cancer: Recent progress and new perspectives
por: Xie, Jiansheng, et al.
Publicado: (2015)